Literature DB >> 11247323

The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis.

A L Herrick, M Matucci Cerinic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11247323

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  35 in total

1.  Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.

Authors:  Amélie Servettaz; Niloufar Kavian; Carole Nicco; Vanessa Deveaux; Christiane Chéreau; Andrew Wang; Andreas Zimmer; Sophie Lotersztajn; Bernard Weill; Frédéric Batteux
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

2.  Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.

Authors:  Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Vladimir Livshitz; Daniel Schapira; Doron Markovits; Alexander Rozin; Tatiana Boikaner; A Menahem Nahir
Journal:  Clin Rheumatol       Date:  2007-03-31       Impact factor: 2.980

3.  Raynaud's phenomenon.

Authors:  Ariane Herrick
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04

Review 4.  New lines in therapy of Raynaud's phenomenon.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

5.  [Primary and secondary Raynaud's phenomenon].

Authors:  J H W Distler
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

Review 6.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

7.  Current Treatment Options in Raynaud's Phenomenon.

Authors:  Sergio Generini; Angela Del Rosso; Alberto Pignone; Marco Matucci Cerinic
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

Review 8.  Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 9.  Animal models of scleroderma: current state and recent development.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

10.  Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis.

Authors:  Valeria Riccieri; Antonio Spadaro; Leos Fuksa; Omidreza Firuzi; Luciano Saso; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-10-27       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.